The Royal Mint and Texas Precious Metals Announce Partnership to Expand Bullion Distribution in the USASHINER, Texas, May 18, 2026 (GLOBE NEWSWIRE) -- The Royal Mint has announced a new distribution partnership with Texas Precious Metals, one of the largest precious metals companies in the United States.
Star Room at Vista del Monte honored for Best Practice/Innovation of the YearSanta Barbara senior living community offers secure, immersive night sky experience for residents
SHAK Investors Have Opportunity to Join Shake Shack Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Shake Shack Inc. (“Shake Shack” or “the Company”) (
NYSE: SHAK) for violations of the securities laws.
YSS Investors Have Opportunity to Join York Space Systems, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of York Space Systems, Inc. (“York” or “the Company”) (
NYSE: YSS) for violations of the securities laws.
Pennant Group to Participate in the 2026 RBC Global Healthcare ConferenceEAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (
NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 RBC Global Healthcare Conference on May 20, 2026. John Gochnour, President and Chief Operating Officer, Lynette Walbom, Chief Financial Officer, and Andy Rider, President of Senior Living, will participate in a fireside chat on May 20, 2026 at 9:30 a.m. Eastern Time. A live webcast of the event will be accessible at https://kvgo.com/rbc/the-pennant-group-inc-may-2026.
Global Water Resources Reports Results of Director ElectionPHOENIX, May 18, 2026 (GLOBE NEWSWIRE) -- Global Water Resources Inc., ("the Company"), (
NASDAQ: GWRS), a pure-play water resource management company, announced that the nominees listed in the Proxy Statement, dated March 31, 2026, for the 2026 Annual Meeting of Stockholders ("the Meeting") were selected as Directors of the Company.
Intuitive Machines Announces Two Prime Lunar Reconnaissance ContractsHOUSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”, together with its subsidiaries, the “Company”), a space technology, infrastructure, and services leader, is now the prime contractor for operations of the Lunar Reconnaissance Orbiter Camera (“LROC”), a key instrument aboard NASA's Lunar Reconnaissance Orbiter ("LRO"), and the ShadowCam instrument, a specialized lunar imaging camera on board the Korea Pathfinder Lunar Orbiter that provides visibility in light obscured conditions such as dark and shadowed regions of the Moon.
Statement on Today’s Massachusetts Jury VerdictNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg is pleased to announce that today, after a five week trial, a nine member federal court jury in Boston, Massachusetts awarded a verdict of $63.2 million in damages to the certified class of end-payor purchasers, led by class representative Premera Blue Cross. The class is comprised of third-party payors who indirectly purchased Amitiza and/or AB-rated generic versions of Amitiza (lubiprostone) in 14 states and the District of Columbia from October 1, 2016 through March 31, 2024.
Exyn Announces Closing of its Initial Public OfferingPHILADELPHIA, PA, May 18, 2026 (GLOBE NEWSWIRE) -- Exyn Technologies, Inc. (“Exyn” or the “Company”) (NASDAQ: EXYN, EXYNW), a leader in autonomous mapping and perception-driven navigation for complex, GPS-denied environments, today announced the closing of its initial public offering (the “Offering”) of 2,500,000 units, with each unit consisting of one share of its common stock (the “Common Stock”) and one warrant to purchase one share of its common stock (the “Warrants”) at a public offering price of $7.75 per unit.
Pennant Announces an Acquisition of Senior Living Community in ArizonaEAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (
NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community, Copper Canyon Memory Care in Tucson, Arizona. The newly acquired community offers memory care services and increases Pennant’s Arizona operations by 40 units.
DRC Congratulates Sarah Eddy, William Savitt, and the Wachtell and Morrison Foerster Trial Team on Their Victory for OpenAI in Musk, et al. v. Altman, et al.OAKLAND, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- DRC congratulates its clients Sarah Eddy, William Savitt, and the entire trial team at Wachtell, Lipton, Rosen & Katz and Morrison Foerster for their successful defense on behalf of Sam Altman, Greg Brockman, the OpenAI Foundation, and OpenAI Group PBC in Musk, et al. v. Altman, et al., Case No. 4:24-cv-04722 (N.D. Cal.). Following a three-week trial, the jury deliberated for less than two hours before reaching a unanimous verdict in favor of OpenAI. Elon Musk brought claims against OpenAI and two of its founders, Sam Altman and Greg Brockman, for breach of charitable trust and unjust enrichment. Musk alleged that Altman and Brockman broke promises to him about the non-profit structure of OpenAI. The Defense showed that no such promises were made, that Musk himself wanted to turn OpenAI into a for-profit, that OpenAI remains a non-profit, and that Musk’s claims were barred by the statute of limitations. Musk also brought a claim for aiding and abetting a breach of charitable trust against Microsoft. After three weeks of trial, the jury deliberated for about ninety minutes before finding that both OpenAI and Microsoft had proven their statute of limitations defense for all claims. Because the Defense prevailed on the statute of limitations, which was the very first question on the verdict form, the jury did not need to consider the merits of Musk’s claims. Judge Yvonne Gonzalez Rogers adopted the jury’s findings and promptly dismissed all of Musk’s claims from the bench. DRC congratulates Defense counsel Sarah Eddy, William Savitt, Bradley Wilson, Nathaniel Cullerton, Randall Jackson, Steven Winter, Kelsey Borenzweig, and Zachary David of Wachtell, Lipton, Rosen & Katz, and William Frentzen, Jordan Eth, David Wiener, and Camila Tapernoux of Morrison Foerster. DRC assisted the trial team with jury research, jury selection, trial graphics, at-trial technology support, and trial strategy consulting.
Egnyte Targets Data Fragmentation with Automated Email and Content GovernanceEmail Capture centralizes siloed communications repositories, and new AEC capabilities ensure business-critical decisions are searchable, secure, and ready for AI
Blaze Pizza Partners With Folds of Honor for Memorial Day Give-Back Initiative$1 From Every 11-Inch Pizza Sold on May 25 Will Support Educational Scholarships for Families of Fallen and Disabled Heroes
Iron Dome Acquisition I Corp. Announces Closing of $150 Million Initial Public OfferingNew York, New York, May 18, 2026 (GLOBE NEWSWIRE) -- Iron Dome Acquisition I Corp. (the “Company”), a special purpose acquisition company, today announced the closing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “IDACU” on May 15, 2026. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “IDAC” and “IDACW,’’ respectively.
Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd to Seek Lead Plaintiff Role in Class Action LawsuitBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Atara (ATRA) To Contact Him Directly To Discuss Their Options
UK sends largest ever business delegation to the US for Greater Together Los AngelesLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- His Majesty the King sent a personal message of support to more than 250 British business and cultural leaders preparing to fly to Los Angeles this weekend for Greater Together LA, the largest ever UK trade and investment mission to the United States.
U-BX Technology Ltd. Announces Effective Date of Reverse Stock SplitNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- U-BX Technology Ltd. (the "Company" or "U-BX") (
NASDAQ:UBXG), a leading company providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers, today announced that it has resolved to effect a reverse stock split of the Company’s class A ordinary shares and class B ordinary shares and has determined the ratio to be 1-for-25. At the Company’s annual meeting of shareholders held on November 4, 2025, the Company’s shareholders approved a reverse stock split at a ratio of not less than 1-for-2 and not more than 1-for-250 and granted the Company’s Board of Directors the authority to determine the exact split ratio. On May 12, 2026, the Company’s Board of Directors determined the ratio to be 1-for-25. U-BX’s class A ordinary shares will begin trading on an adjusted basis giving effect to the reverse stock split on May 22, 2026 under the existing ticker symbol “UBXG”. The new CUSIP number of the Company’s class A ordinary shares will be G9161K120.
Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 CongressCAMBRIDGE, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today announced that initial clinical data from two ongoing Phase 1 studies evaluating CLN-978, a subcutaneously administered CD19xCD3 T cell engager, will be presented at the European Alliance of Associations for Rheumatology (EULAR) European Congress of Rheumatology being held June 3-6, 2026 in London, United Kingdom.
Antalpha Announces Strategic Expansion Into AI InfrastructureSINGAPORE, May 18, 2026 (GLOBE NEWSWIRE) -- Antalpha (
NASDAQ: ANTA) (“Antalpha” or the “Company”), today announced a broader strategic expansion into AI infrastructure and intelligent routing systems as an additional growth vector aligned with the Company’s evolving long-term technology roadmap.
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms DosingMELBOURNE, Australia and INDIANAPOLIS, May 19, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the IPAX-2 study1 of TLX101-Tx (¹³¹I-iodofalan) in patients with newly diagnosed glioblastoma has completed patient enrolment. No dose-limiting toxicities (DLTs) have been observed to date, including with two doses of 5GBq (total administered activity of 10GBq), the maximum administered dose in the study.
Bragar Eagel & Squire, P.C. Urges Coty, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their Rights Before May 22ndBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Coty To Contact Him Directly To Discuss Their Options
Destinations Career Academy of New Mexico (NMDCA) Graduates More Than 220 StudentsClass of 2026 spans 24 of New Mexico’s 33 counties, representing the full diversity of communities across the state
Dave’s Hot Chicken Serves Up More of What Fans Love with the Launch of Dave’s Big TrioDave’s Bites, Hot Mozz, and fan-favorite Mini Sliders Served Together Beginning May 19
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly DosingData reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with monthly dosing
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)RESEARCH TRIANGLE PARK, N.C., May 18, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (
NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on May 11, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of stock option awards (“Stock Options”) to purchase an aggregate of 50,000 of the Company’s common shares to three new non-executive employees of the Company with a grant date of May 18, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The Stock Options consist of incentive stock options to purchase an aggregate of 49,141 shares and nonqualified stock options to purchase an aggregate of 859 shares. The Stock Options were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
HERCULES CAPITAL DEADLINE MAY 19th: Bragar Eagel & Squire, P.C. Urges Hercules Capital Investors with Large Losses to Contact the Firm Before May 19th Regarding Their RightsBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hercules Capital (HTGC) To Contact Him Directly To Discuss Their Options
Certara to Participate in Upcoming Investor ConferencesRADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that on May 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted an aggregate of 51,075 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
Latham Group, Inc. to Participate at Conferences in May and June 2026LATHAM, N.Y., May 18, 2026 (GLOBE NEWSWIRE) -- Latham Group, Inc. (
NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that management will attend the following investor conferences:
Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare ConferenceBURLINGTON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York, NY.
AvePoint to Participate in Upcoming Investor ConferencesJERSEY CITY, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in AI data protection, unifying data security, governance, and resilience, today announced that members of the Company’s executive management team will present at the following investor conferences:
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to three new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on May 11, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).
Valley National Bancorp Declares its Regular Quarterly Preferred and Common Stock DividendsNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Valley National Bancorp (
NASDAQ:VLY) (“Valley”), the holding company for Valley National Bank, announced today its regular preferred and common dividends. The declared quarterly dividends to shareholders of record on June 15, 2026 are as follows:
MediaAlpha Appoints Lauren StClair to Board of DirectorsVeteran Public-Company CFO Brings 20+ Years of Technology Finance Leadership
Solo Brands, Inc. to Present and Host 1x1 Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026GRAPEVINE, Texas, May 18, 2026 (GLOBE NEWSWIRE) -- Solo Brands, Inc. (OTCQB: SBDS) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel industries, today announced that management will participate in the 16th Annual East Coast IDEAS Investor Conference at The Westin New York at Times Square on June 11, 2026.
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 85,480 shares of the Company’s common stock to one new employee (the “Inducement Grant”), with the grant made on May 18, 2026 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering employment with C4T in accordance with Nasdaq Listing Rule 5635(c)(4).
Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in SwitzerlandSAN DIEGO, May 18, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (
NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted tinlarebant, the Company’s lead product candidate, orphan drug status (ODS) for the treatment of Stargardt disease (STGD1), a rare, inherited retinal disorder caused by mutations in the ABCA4 gene.
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International ConferencePresentation Features Additional Data from the Single-dose Cohorts of the Phase 1/2 Trial, Including Detailed Safety Results, Efficacy Durability and Reduction in Human Neutrophil Elastase Activity Post-BEAM-302 Treatment
DeGen Medical Expands Patient-Specific Spine PlatformFlorence, SC, May 18, 2026 (GLOBE NEWSWIRE) -- DeGen Medical announced continued expansion of its patient-specific implant (PSI) platform designed to provide surgeons with patient-specific solutions for complex spinal pathologies while maintaining compatibility with a streamlined off-the-shelf workflow.
project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS ExpansionShipper new ARR surges 52% year over year as enterprise logistics leaders deepen commitment to the Decision Intelligence Platform
Litigator Steven E. Frankel Joins Garfunkel WildNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Garfunkel Wild, P.C. is pleased to announce that Steven E. Frankel, an accomplished litigator, has joined the firm as a partner in its Garden City, New York office serving in the firm’s Litigation and Alternative Dispute Resolution Practice Group. Steven will focus on complex commercial litigation and employment matters.
MTRX Investors Have Opportunity to Join Matrix Service Company Fraud Investigation with the Schall Law FirmLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Matrix Service Company (“Matrix” or “the Company”) (
NASDAQ: MTRX) for violations of the securities laws.
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cencora, Inc. (“Cencora” or “the Company”) (
NYSE: COR) for violations of the securities laws.
AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or “the Company”) (
NASDAQ: AZTA) for violations of the securities laws.
University of Miami business school rises to No. 2 in executive education in the nationFinancial Times ranking highlights the business school’s growing reputation in custom executive learning.
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly DividendCINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) -- Stockholders of Chemed Corporation (
NYSE: CHE) today elected a slate of nine directors at the Company’s 2026 annual stockholders’ meeting.
BRCB Investors Have Opportunity to Join Black Rock Coffee Bar, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or “the Company”) (
NASDAQ: BRCB) for violations of the securities laws.
SBA Doubles Cumulative 7(a) and 504 Loan Limit to $10 MillionEffective July 4, eligible borrowers can access record levels of SBA-backed funding
25 Years of Bratz®: Big Style, Bigger Launches, and Next-Level CollabsThe Iconic Doll Brand Celebrates 25 Years with a Year-Long Celebration Featuring an All-New Original Podcast, Collector-Worthy Doll Launches, Buzzworthy Collabs, New Music, and More!
Olive Tree People Inc. Subsidiary Announces Launch of Hydroxytyrosol-Based Waterless Pet Brand ‘Is That Matty?’Oliveda International, Inc. subsidiary Olive Tree People Inc. has developed a globally-unique, hydroxytyrosol-based "waterless" pet brand to serve a rapidly growing market
CHAMPIONX CORPORATION (CHX) INVESTOR ALERT: Investors Who Sold ChampionX Shares Encouraged to Contact Bernstein Liebhard LLPNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who sold the common stock of ChampionX Corporation (“ChampionX” or the “Company”) (formerly NASDAQ: PHR) between February 29, 2024 and April 1, 2024, inclusive.What To Do Next:
NorthStrive® Companies Inc. Co-Advises on Acquisition of A&B Aerospace, Inc.NEWPORT BEACH, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- NorthStrive® Companies Inc. (“NorthStrive”), a management, advisory, and investment firm, is pleased to announce that it served as co-advisor to PMGC Holdings Inc. (“PMGC”) in connection with the successful acquisition of A&B Aerospace, Inc., a California-based precision aerospace manufacturing company.
ChatGPT Discusses How They are Powering a New Wave of Small Business Growth Across America with YourUpdateTVNationwide media tour conducted by OpenAI in conjunction with D S Simon Media on the topic of how AI Isn’t Just for Tech Giant’s. Small Businesses Are Using It to Win Now.
UPDATE - New bp rewards Visa® cardmembers save 50 cents per gallon on fuelCHICAGO, May 18, 2026 (GLOBE NEWSWIRE) -- This summer, bp is offering new bp rewards Visa® cardmembers a limited time introductory offer of 50 cents off every gallon1 of fuel at bp and Amoco stations for the first 60 days. For a new cardmember who fills up their 15-gallon tank once a week, that equals more than $60 of savings in just two months3. This limited time offer is available to new bp rewards Visa cardmembers who apply by September 30, 2026.
The Power of Sharing a Table: How Americans are Reviving ‘IRL’ Experiences with Drinks, Dinners and BeyondNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) Real-world connection has become increasingly rare and if you’ve felt the effects, you’re not alone. After years of digital-first habits becoming the new norm, many people are looking to rediscover face-to-face social interaction – “IRL,” in real life, not from behind a screen.
